BDBM205077 US9556132, 56::process for preparing 2-{5-[2-(2-methoxyphenyl)phenyl]-1h-1,2,3,4-tetrazol-1-yl}benzonitrile
SMILES: COc1ccccc1-c1ccccc1-c1nnnn1-c1ccccc1C#N
InChI Key: InChIKey=LNAQIXTYHXVLRI-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intermediate conductance calcium-activated potassium channel protein 4 (Homo sapiens (Human)) | BDBM205077 (US9556132, 56 | process for preparing 2-{5-[2-(2-m...) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 64 | n/a | n/a | n/a | n/a | 7.3 | n/a |
Saniona A/S US Patent | Assay Description Human HEK293 cells over-expressing human IK are grown in culture medium (DMEM supplemented with 10% foetal bovine serum), in polystyrene culture flas... | US Patent US9556132 (2017) BindingDB Entry DOI: 10.7270/Q2SF2Z5T | |||||||||||
More data for this Ligand-Target Pair |